Insmed (INSM) Payables (2010 - 2026)

Insmed has reported Payables for 17 years, with the latest figure at $428.9 million in Q2 2026.

• On a quarterly basis, Payables rose 40.62% year-over-year to $428.9 million in Q2 2026; TTM through Jun 2026 was $428.9 million, a 40.62% increase from a year earlier, with the FY2025 full-year figure at $456.1 million, up 59.9% from the prior year.
• Payables was $428.9 million for Q2 2026 at Insmed, up from $352.6 million in the prior quarter.
• The five-year high for Payables was $456.1 million in Q4 2025, with the low at $31.1 million in Q2 2022.
• Average Payables over 5 years is $267.9 million, with a median of $285.2 million recorded in 2024.
• The largest YoY upside for Payables was 116.62% in 2022 against a maximum downside of 0.2% in 2022.
• Over 5 years, Payables stood at $182.1 million in 2022, then climbed by 18.05% to $215.0 million in 2023, then jumped by 32.66% to $285.2 million in 2024, then soared by 59.9% to $456.1 million in 2025, then declined by 5.95% to $428.9 million in 2026.
• The last three Payables figures came in at $428.9 million (Q2 2026), $352.6 million (Q1 2026), and $456.1 million (Q4 2025), per Business Quant data.